Qualitek Labs will convene its Board of Directors on Tuesday, September 22, 2026, to evaluate proposals for capital infusion. The agenda includes the potential issuance of equity-linked instruments or other securities.

The company intends to explore various permissible modes for fundraising under the Companies Act, 2013, and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Options under consideration include a rights issue, preferential allotment, or private placement.

Regulatory Compliance and Trading Window

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the exchange was notified of the meeting. A trading window remains closed for designated persons, including directors, promoters, and their immediate relatives.

The restriction is effective from September 17, 2026, until 48 hours after the conclusion of the board meeting. This period extends through September 24, 2026.

Shareholder Approval Process

The board may seek approval from shareholders for the fundraising proposal by convening a General Meeting. This step is contingent upon the specific terms and conditions deemed appropriate by the board and its committees.

The notice of the meeting is available on the company’s website and the BSE portal. Antaryami Nayak, Managing Director, signed the intimation.

Qualitek Labs has withdrawn the proposal to increase the overall managerial remuneration limit to 35% from its Eighth Annual General Meeting (AGM) notice. The board approved this withdrawal via a circular resolution on September 7, 2026.

The company scheduled its AGM for September 25, 2026, at Avanta Business Centre in New Delhi. Shareholders can participate via remote e-voting from September 22 to September 24, 2026. The cut-off date for e-voting eligibility is September 18, 2026.

Withdrawal of Remuneration Proposal

The original draft notice, approved on August 29, 2026, included Item No. 4 as a Special Resolution to raise the remuneration payable to Directors, including the Managing Director and Whole-Time Directors, from 28% to 35% of net profits. This calculation is based on Section 198 of the Companies Act, 2013.

Following the board’s decision on September 7, 2026:

• Item No. 4 will not be considered, discussed, or put to vote at the AGM.
• No remote e-voting or voting at the AGM will be conducted for this item.
• The existing approval of members regarding the 28% managerial remuneration limit, approved at the Seventh AGM, remains in force.

Other Board Approvals

The withdrawal of Item No. 4 does not affect other businesses proposed in the AGM notice. The board previously considered several governance matters during its meeting at the Noida corporate office:

• AGM Notice: Approved the draft notice for FY26, including ordinary and special business items.
• Directors' Report: Approved the draft report along with annexures for member consideration.
• Tax Auditor: Re-appointed M/s J Madan & Associates as Tax Auditor for FY27 (Assessment Year 2027-28).
• Scrutinizer: Appointed CS Ronak Jhuthawat as scrutinizer for the e-voting process.
• E-voting Agency: Appointed Central Depository Services (India) Limited (CDSL) to facilitate voting.

Director Re-appointment

The board recommended the re-appointment of Antaryami Nayak, who retires by rotation at the ensuing AGM. Nayak, who has served as Managing Director since May 2, 2023, brings extensive experience in the Testing, Inspection and Certification (TIC) sector, finance, and business strategy.

Related Party Transactions

The board approved entering into material Related Party Transactions during FY27, subject to Audit Committee approval and shareholder consent. These transactions will comply with Section 188 of the Companies Act, 2013, and Regulation 23 of SEBI Listing Regulations.